Skip to Content

Join the 'Prostate Cancer' group to help and get support from people like you.

Prostate Cancer News

Related terms: Cancer, Prostate, Carcinoma of Prostate

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 3 days ago by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer Collaboration study. The lifetime risk of developing cancer was one in three for men and one in four for women, the researchers said. Prostate cancer was the most common type of cancer in men (1.6 million cases), and tracheal, bronchus and lung cancer was the leading cause of cancer death in men. Breast cancer was the most common cancer for women (2.4 million cases), and the leading cause of cancer death in women. The most common cancers in children were leukemia, other neoplasms, non-Hodgkin ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Melanoma, Skin Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Cancer, Testicular Cancer, Salivary Gland Cancer, Solid Tumors

Cancer Advances Demand Continual Funding, Specialists Say

Posted 8 days ago by Drugs.com

TUESDAY, Nov. 29, 2016 – Sufficient and sustained funding for cancer research should be a global priority, European and American cancer organizations said at the start of an international oncology conference in Germany on Tuesday. Significant progress has been made in the understanding of how cancer develops. But, consistent research funding is needed to take advantage of these advances to improve cancer survival rates, according to specialists from two of the cancer organizations sponsoring the Munich meeting. "There has never been a more exciting time in cancer research," said Dr. Denis Lacombe, director general of the European Organisation for Research and Treatment of Cancer (EORTC). "With the surge in molecular biology developments and a growing consideration for cost-benefit balance from a public health perspective, there is an increasing need to invest in cancer research and ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Bladder Cancer, Head and Neck Cancer

Cancer Can Devour Income of Medicare-Only Patients

Posted 14 days ago by Drugs.com

WEDNESDAY, Nov. 23, 2016 – Medical bills for older U.S. cancer patients can eat up one-quarter of their income or more if they have Medicare without supplemental insurance, a new study says. Hospitalization is a major reason why seniors with the government-funded insurance program have high out-of-pocket costs for cancer care, the researchers concluded. "The spending associated with a new cancer diagnosis gets very high quickly, even if you have insurance," said study co-author Lauren Hersch Nicholas, an assistant professor at the Bloomberg School of Public Health at Johns Hopkins University in Baltimore. "The physical disease is terrible and then you have to figure out how to deal with the economic fallout associated with paying to treat it," she said in a university news release. Nicholas and her colleagues examined data from more than 1,400 Medicare patients diagnosed with cancer ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer

Palliative Care Raises Quality of Life, But Doesn't Extend It

Posted 15 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – Palliative care can ease the burden that a serious illness places on both a patient and loved ones, but there's no evidence that it can extend the life of a sick person, a review of the available evidence has concluded. People who receive palliative care have better quality of life and fewer symptoms than people who don't receive such care, said study lead author Dio Kavalieratos. He is an assistant professor at the University of Pittsburgh School of Medicine's Section of Palliative Care and Medical Ethics. But there's no evidence that palliative care has any impact on how long a patient will live, Kavalieratos added. "We didn't find an association at all," he said. "There was no relationship between receiving palliative care and time until death." Palliative care focuses on providing seriously ill patients relief from their symptoms, pain and stress, ... Read more

Related support groups: Pain, Anxiety and Stress, Cancer, Breast Cancer, Prostate Cancer, Breast Cancer - Palliative

Alcohol May Fuel Prostate Cancer Risk

Posted 16 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – Drinking may raise the risk of prostate cancer, and the more men drink the greater their risk, a new analysis of 27 studies suggests. Canadian and Australian scientists found a significant association between alcohol and prostate cancer risk, though they did not prove that drinking caused prostate cancer risk to rise. Even low levels of drinking (up to two drinks a day) were associated with an 8 to 23 percent higher risk of prostate cancer when compared to no drinking, the researchers said. "This new study contributes to the strengthening evidence that alcohol consumption is a risk factor for prostate cancer. Alcohol's contribution to prostate cancer will need to be factored into future estimates of the global burden of disease," said study co-author Tim Stockwell in a University of Victoria news release. He is director of the university's Centre for Addictions ... Read more

Related support groups: Prostate Cancer, Alcohol Dependence, Alcoholism, Hangover, Acute Alcohol Intoxication

Exercise Good for Cancer Patients During, After Treatment

Posted 15 Nov 2016 by Drugs.com

TUESDAY, Nov. 15, 2016 – Exercising during and after cancer treatment is safe and improves quality of life, fitness and physical functioning, new research indicates. Benefits occurred with all types of exercise, said study author Brian Focht. "Overall, resistance exercise, aerobic exercise – and even a combination of aerobic and resistance – resulted in improvement in fitness and quality of life and physical function," said Focht. He directs the exercise and behavioral medicine lab at the Ohio State University Comprehensive Cancer Center in Columbus. More than 15 million people in the United States are cancer survivors. That number is expected to rise to 20 million within 10 years, according to background information with the study. But current guidelines about exercise for cancer survivors are broad, suggesting simply that patients should try to be active, Focht noted. The study ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Second Opinions Don't Seem to Sway Prostate Cancer Patients

Posted 8 Nov 2016 by Drugs.com

MONDAY, Nov. 7, 2016 – Second opinions have little impact on prostate cancer patients' treatment decisions, new research suggests. The study included nearly 2,400 men in the Philadelphia area recently diagnosed with localized prostate cancer. Forty percent of the men obtained a second opinion from urologists, most often because they wanted more information about their cancer (51 percent) or wanted to be seen by the best doctor (46 percent). Overall, obtaining second opinions was not associated with changes in treatment choice or with improvements in how patients viewed their quality of cancer care. The researchers also found that patients who obtained second opinions because they wanted more information, were seeking the best doctor, or had been encouraged to do so by family or friends were more likely to undergo surgery. This suggests that for some men, second opinions offer a way to ... Read more

Related support groups: Cancer, Prostate Cancer

Gene Test May ID Chemo Patients at Risk of Clots: Study

Posted 1 Nov 2016 by Drugs.com

TUESDAY, Nov. 1, 2016 – Genetic testing could help identify breast cancer patients at high risk for the formation of blood clots in their veins, new research suggests. This problem, called venous thromboembolism (VTE), is a serious and potentially fatal complication that can occur during cancer treatment, particularly chemotherapy. Because breast cancer is one of the most common cancers, breast cancer patients account for a large number of cancer-related VTE cases, said study author Judith Brand. She's a postdoctoral researcher in the department of medical epidemiology and biostatistics at Karolinska Institute in Stockholm, Sweden. Venous thromboembolism is preventable through treatment with an anti-clotting drug. But side effects, such as bleeding, mean this therapy is not routinely used in patients undergoing chemotherapy, the researchers explained. The new study included more than ... Read more

Related support groups: Blood Disorders, Cancer, Warfarin, Coumadin, Breast Cancer, Xarelto, Prostate Cancer, Pradaxa, Lovenox, Eliquis, Lung Cancer, Colorectal Cancer, Heparin, Melanoma, Rivaroxaban, Enoxaparin, Fragmin, Apixaban, Clexane, Arixtra

High Rate of Antidepressant Use After Cancer

Posted 27 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those who never had the disease, a new study finds. Among more than 3,000 adult cancer survivors, 19 percent reported taking medication for anxiety, depression or both, researchers found. But when the research team looked at nearly 45,000 adults with no history of cancer, they found just one in 10 used these medications. "Overall, these findings are sobering," said lead researcher Nikki Hawkins, a behavioral scientist at the U.S. Centers for Disease Control and Prevention. "We've come a long way in treating cancer medically, but these data tell us cancer can take a serious psychological and emotional toll for many years, even after treatment is complete," she said. Hawkins said it's remarkable that nearly one in five cancer survivors is taking medications ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Major Depressive Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Colorectal Cancer, Dysthymia, Melanoma, Breast Cancer - Adjuvant, Cervical Cancer

Monitoring, Not Treatment, May Be Better for Some Prostate Cancer Patients

Posted 20 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – More than 90 percent of men in Sweden who have very low-risk prostate cancer choose close monitoring rather than immediate treatment – and more American men should use that option, researchers say. In a study of nearly 33,000 Swedish men with very low-risk (stage T1) prostate cancer diagnosed between 2009 and 2014, the number choosing what is called active surveillance increased from 57 percent to 91 percent during that time frame. "For men who are diagnosed with low-risk prostate cancer, it is important to know that active surveillance is an accepted way to manage the cancer," said lead researcher Dr. Stacy Loeb. She's an assistant professor in the departments of urology and population health at NYU Langone's Perlmutter Cancer Center in New York City. "There is no rush to get treatment – low-risk prostate cancer can be safely monitored," she added. "Some ... Read more

Related support groups: Prostate Cancer, Diagnosis and Investigation

Smokeless Tobacco Product Tied to Higher Risk of Prostate Cancer Death

Posted 14 Oct 2016 by Drugs.com

FRIDAY, Oct. 14, 2016 – Smokeless tobacco called snus may increase a prostate cancer patient's risk of death, according to a new study. "Snus has been suggested as a less harmful alternative to smoking because it lacks the combustion products of smoking that are associated with cancer risk," said study co-first author Kathryn Wilson. She is a research scientist at the Harvard T.H. Chan School of Public Health in Boston. "However, we found that men with prostate cancer who used snus were at increased risk of premature death," Wilson said in a Harvard news release. Snus – pronounced like "goose" – is used mainly in Sweden but is also available in the United States. Often sold in tea bag-like sachets, the powdered tobacco product is placed under the upper lip for extended periods, the researchers explained. Wilson and her colleagues analyzed health check-up data from thousands of men in ... Read more

Related support groups: Smoking, Prostate Cancer, Smoking Cessation, Nicotine, Nicorette, Nicoderm CQ, Nicotrol Inhaler, Commit, Habitrol, ProStep, Nicotrol TD, Nicorelief, Nicorette DS, Nicotrol NS

Can Hormonal Rx for Prostate Cancer Raise Dementia Risk?

Posted 13 Oct 2016 by Drugs.com

THURSDAY, Oct. 13, 2016 – The risk of dementia might be doubled for prostate cancer patients who are treated with testosterone-lowering drugs, a new study suggests. Men who underwent androgen-deprivation therapy (ADT) had close to an 8 percent risk of developing dementia within five years of treatment, compared with a 3.5 percent risk for prostate cancer patients who didn't receive the therapy, researchers discovered. "People who got ADT in our study had twice the risk of developing dementia, compared to people who didn't," said lead researcher Dr. Kevin Nead. He is a radiation oncology resident at the University of Pennsylvania who conducted the research while at Stanford University in California. But, the study only found an association between ADT and dementia risk, not cause and effect. And men undergoing androgen therapy shouldn't stop the treatment based on these findings, the ... Read more

Related support groups: Prostate Cancer, Casodex, Bicalutamide, Xtandi, Flutamide, Nilandron, Nilutamide, Eulexin, Enzalutamide

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

Hormone Therapy for Prostate Cancer Less Safe for Men With Prior Heart Attack

Posted 30 Sep 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – Men diagnosed with prostate cancer often receive hormone-depleting therapy to help fight the tumor. But a new study suggests that the treatment may pose a risk to men who've previously suffered a heart attack. "Patient age, cardiac risk, and disease recurrence risk should be considered when selecting candidates for hormone therapy in this patient population," lead researcher Dr. Nataniel Lester-Coll of Yale University said in a Yale news release. He's a resident doctor at the Yale School of Medicine's department of therapeutic radiology in New Haven, Conn. Because prostate tumors typically grow in the presence of hormones such as testosterone, doctors often recommend therapies that temporarily deplete hormone levels. But might that approach affect heart health? To find out, the Yale team analyzed data from patients with intermediate- and high-risk prostate ... Read more

Related support groups: Heart Attack, Testosterone, Prostate Cancer, AndroGel, Testim, Axiron, Myocardial Infarction, Androderm, Fortesta, Depo-Testosterone, Testopel, Testopel Pellets, Myocardial Infarction - Prophylaxis, Testim 5 g/packet, Delatestryl, Striant, AndroGel 1.25 g/actuation, Delatestadiol, FIRST-Testosterone MC, Andro-Cyp 200

Vasectomy May Not Raise Prostate Cancer Risk After All

Posted 19 Sep 2016 by Drugs.com

MONDAY, Sept. 19, 2016 – A large, new study challenges previous research that suggested vasectomies might increase the risk of prostate cancer or dying from it. In the latest finding, researchers found no connection between vasectomies and overall risk of prostate cancer, or of dying from the disease. The American Cancer Society epidemiologists reviewed more than 7,000 prostate cancer deaths, as opposed to the just over 800 prostate cancer deaths that were studied by Harvard scientists in a 2014 study. "Vasectomy is an effective and inexpensive long-term method of birth control," said new study author Eric Jacobs. "This new, large study provides some reassurance that vasectomy is unlikely to meaningfully increase risk of prostate cancer." Jacobs and his colleagues reviewed data on almost 364,000 men aged 40 and older who participated in the Cancer Prevention Study II, a vast research ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Prostate Cancer, Postcoital Contraception, Prostatitis, Prostate Tumor - Benign, Genitourinary Surgical and Other Conditions

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

estradiol, Lupron, Premarin, ethinyl estradiol, Estrace, Lupron Depot, Zoladex, Zytiga, Estradiol Patch, view more... Casodex, Cenestin, Taxotere, Eligard, Enjuvia, cyclophosphamide, bicalutamide, Xtandi, capecitabine, flax, leuprolide, Menest, degarelix, Xofigo, Provenge, Trelstar, docetaxel, abiraterone, goserelin, Vantas, Firmagon, Progynova, conjugated estrogens, Supprelin LA, Flax Seed Oil, Trelstar LA, Trelstar Depot, flutamide, Thais, Sandrena, cabazitaxel, triptorelin, Premarin Intravenous, esterified estrogens, Jevtana, Lupron Depot 11.25 mg, sipuleucel-t, Cytadren, Delestrogen, radium 223 dichloride, Viadur, mitoxantrone, histrelin, Estratab, enzalutamide, nilutamide, Nilandron, Novantrone, abarelix, Zoladex 3-Month, diethylstilbestrol, Docefrez, estramustine, Estinyl, Stilphostrol, Zumenon, Emcyt, Plenaxis, Progynova TS, aminoglutethimide, Primogyn Depot, Oromone, Thaissept, Eulexin, Systen, Provames, Valergen